Novartis leads race to acquire Monjuvi maker MorphoSys: Reuters
Fierce Pharma
FEBRUARY 5, 2024
After Novartis reportedly backed out of late-stage talks to acquire Cytoki | The company has a leading bid for the cancer drug maker over Incyte, Reuters reports, citing two people familiar with the matter.
Let's personalize your content